Bank of America
ORKA

Bank of America’s Oruka Therapeutics ORKA Stock Holding History

Bank of America’s Portfolio ORKA Stock Details ORKA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$33.6M Buy
352,824
+252,733
+253% +$16.8M ﹤0.01% 2033
2026
Q1 		$4.91M Sell
100,091
-39,181
-28% -$1.36M ﹤0.01% 3490
2025
Q4 		$4.22M Buy
139,272
+60,277
+76% +$1.68M ﹤0.01% 3524
2025
Q3 		$1.52M Buy
78,995
+60,146
+319% +$892K ﹤0.01% 5042
2025
Q2 		$211K Buy
18,849
+13,986
+288% +$146K ﹤0.01% 6160
2025
Q1 		$49.9K Buy
4,863
+4,665
+2,356% +$58.2K ﹤0.01% 6747
2024
Q4 		$3.84K Buy
198
+183
+1,220% +$4.46K ﹤0.01% 7127
2024
Q3 		$368 Buy
15
+2
+15% +$70 ﹤0.01% 7442
2024
Q2 		$579 Sell
13
-2
-13% -$80 ﹤0.01% 7333
2024
Q1 		$310 Buy
15
+11
+275% +$219 ﹤0.01% 7318
2023
Q4 		$73 Buy
4
+1
+33% +$22 ﹤0.01% 7446
2023
Q3 		$62 Hold
3
– – ﹤0.01% 7496
2023
Q2 		$63 Hold
3
– – ﹤0.01% 7451
2023
Q1 		$62 Sell
3
-2
-40% -$53 ﹤0.01% 7509
2022
Q4 		$153 Buy
5
+2
+67% +$51 ﹤0.01% 7594
2022
Q3 		$0 Hold
3
– – ﹤0.01% 8258
2022
Q2 		$0 Hold
3
– – ﹤0.01% 8465
2022
Q1 		$0 Sell
3
-2
-40% -$50 ﹤0.01% 8860
2021
Q4 		$0 Sell
5
-4
-44% -$121 ﹤0.01% 8715
2021
Q3 		$0 Buy
9
+6
+200% +$222 ﹤0.01% 8444
2021
Q2 		$0 Hold
3
– – ﹤0.01% 8149
2021
Q1 		$0 Hold
3
– – ﹤0.01% 7851
2020
Q4 		$0 Hold
3
– – ﹤0.01% 7418
2020
Q3 		$0 Sell
3
-1
-25% -$71 ﹤0.01% 7224
2020
Q2 		$0 Buy
4
+1
+33% +$65 ﹤0.01% 7173
2020
Q1 		$0 Hold
3
– – ﹤0.01% 7313
2019
Q4 		$0 Hold
3
– – ﹤0.01% 7470
2019
Q3 		$0 Hold
3
– – ﹤0.01% 7555
2019
Q2 		$0 Hold
3
– – ﹤0.01% 7454
2019
Q1 		$0 Hold
3
– – ﹤0.01% 7464
2018
Q4 		$0 Hold
3
– – ﹤0.01% 7430
2018
Q3 		$0 Hold
3
– – ﹤0.01% 7509
2018
Q2 		$0 Sell
3
-1
-25% -$117 ﹤0.01% 7370
2018
Q1 		$0 Hold
4
– – ﹤0.01% 7388
2017
Q4 		$1K Buy
4
+1
+33% +$290 ﹤0.01% 6939
2017
Q3 		$1K Hold
3
– – ﹤0.01% 6958
2017
Q2 		$1K Hold
3
– – ﹤0.01% 6846
2017
Q1 		$1K Hold
3
– – ﹤0.01% 6877
2016
Q4 		$2K Sell
3
-10
-77% -$5.32K ﹤0.01% 6858
2016
Q3 		$9K Buy
13
+10
+333% +$6.44K ﹤0.01% 6435
2016
Q2 		$2K Hold
3
– – ﹤0.01% 6917
2016
Q1 		$2K Hold
3
– – ﹤0.01% 6795
2015
Q4 		$3K Sell
3
-7
-70% -$7.93K ﹤0.01% 7033
2015
Q3 		$11K Hold
10
– – ﹤0.01% 6531
2015
Q2 		$18K Hold
10
– – ﹤0.01% 6379
2015
Q1 		$12K Hold
10
– – ﹤0.01% 6245
2014
Q4 		$14K Sell
10
-1
-9% -$1.51K ﹤0.01% 6939
2014
Q3 		$20K Sell
11
-32
-74% -$66.8K ﹤0.01% 7041
2014
Q2 		$94K Sell
43
-1
-2% -$2.33K ﹤0.01% 6192
2014
Q1 		$124K Sell
44
-3
-6% -$8.77K ﹤0.01% 5811
2013
Q4 		$119K Buy
47
+1
+2% +$2.31K ﹤0.01% 5996
2013
Q3 		$110K Hold
46
– – ﹤0.01% 5911
2013
Q2 		$89K Buy
+46
New +$140K ﹤0.01% 6223

Other funds holding ORKA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Bank of America's ORKA Position: Q2 2026 in Review

Bank of America increased its Oruka Therapeutics (ORKA) stake by 253% in Q2 2026, buying an estimated $16.8M and bringing the position to 352,824 shares worth $33.6M. The position accounts for ﹤0.01% of the portfolio, ranked #2033.

Bank of America first reported a position in ORKA in Q2 2013 and has held it in 53 quarters since. 256 funds tracked by Wall St. Rank hold ORKA as of Q2 2026.

  • Bank of America held 352,824 shares of Oruka Therapeutics worth $33.6M as of Q2 2026.
  • Bank of America bought 252,733 Oruka Therapeutics shares in Q2 2026, an estimated $16.8M.
  • Oruka Therapeutics made up ﹤0.01% of Bank of America's portfolio in Q2 2026, its #2033 holding.
  • Bank of America first reported a position in Oruka Therapeutics in Q2 2013 and has held it in 53 quarters since.
  • 256 funds tracked by Wall St. Rank held Oruka Therapeutics as of Q2 2026.

Based on Bank of America's 13F filing for Q2 2026, filed 14 Aug 2026.